Investors that joined the round include Japan’s Medipal Holdings Corporation and Ci:z Investment, Mirae Asset Capital and Korea Investment Partners. The post Japanese investors co-lead European biotech firm Promethera’s $44m Series D appeared first on DealStreetAsia.